Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Ryan W. Huey

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-7887-8484; OpenAlex author ID A5064540759. Sources: ClinicalTrials.gov.

Their work

Papers
6
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
42
Papers, trials and grants by year

2021: 1 paper, 1 trial · 2022: none · 2023: none · 2024: 1 paper · 2025: 2 papers · 2026: 2 papers

Papers 6

  1. Phase I trial of binimetinib plus hydroxychloroquine in patients with previously treated metastatic pancreatic cancer. Co-author DOI 10.1093/oncolo/oyag071↗
  2. Site-Specific Outcomes and Genomics in Metastatic Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1093/oncolo/oyag423↗
  3. Trends Over Time in Recurrence Patterns and Survival Outcomes after Neoadjuvant Therapy and Surgery for Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000006269↗
  4. KRAS mutation detection by liquid biopsy for pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s13045-025-01696-0↗
  5. Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma (EXTEND): A Multicenter, Randomized Phase II T… Co-author DOI 10.1200/jco.24.00081↗
  6. Implementation of a stereotactic body radiotherapy program for unresectable pancreatic cancer in an integrated community academic radiation oncology satellite … Co-author DOI 10.1016/j.ctro.2021.02.004↗

Trials 1

  1. Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events Principal investigator NCT05038254↗

Closest collaborators

The 25 strongest of 42 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Robert A. Wolff · 5 shared papers, 2024–2026 · strength 0.96
  2. Brandon George Smaglo · 5 shared papers, 2024–2026 · strength 0.96
  3. Shubham Pant · 5 shared papers, 2024–2026 · strength 0.96
  4. Eugene Jon Koay · 5 shared papers, 2021–2026 · strength 0.83
  5. Jason A. Willis · 4 shared papers, 2024–2026 · strength 0.74
  6. Matthew H. G. Katz · 4 shared papers, 2024–2026 · strength 0.72
  7. Michael James Overman · 3 shared papers, 2025–2026 · strength 0.59
  8. Anirban Maitra · 3 shared papers, 2025–2026 · strength 0.59
  9. Naruhiko Ikoma · 3 shared papers, 2025–2026 · strength 0.58
  10. Rebecca Anne Snyder · 3 shared papers, 2025–2026 · strength 0.58
  11. Dan Zhao · 3 shared papers, 2024–2026 · strength 0.54
  12. Ethan Bernard Ludmir · 3 shared papers, 2024–2026 · strength 0.51
  13. Michael P. Kim · 2 shared papers, 2025 · strength 0.38
  14. Ching-Wei David Tzeng · 2 shared papers, 2025 · strength 0.38
  15. Abdelrahman M.G. Yousef · 2 shared papers, 2025–2026 · strength 0.36
  16. Saikat Chowdhury · 2 shared papers, 2025–2026 · strength 0.36
  17. Mahmoud Yousef · 2 shared papers, 2025–2026 · strength 0.36
  18. Haoqiang Ying · 2 shared papers, 2025–2026 · strength 0.36
  19. Albert C. Koong · 2 shared papers, 2021–2024 · strength 0.25
  20. Cullen M. Taniguchi · 2 shared papers, 2021–2024 · strength 0.25
  21. J. Jack LEE · 1 shared paper, 2026 · strength 0.23
  22. Saurav Daniel Haldar · 1 shared paper, 2026 · strength 0.23
  23. Rishi Surana · 1 shared paper, 2026 · strength 0.23
  24. Channing J. Der · 1 shared paper, 2026 · strength 0.23
  25. Florencia M. McAllister · 1 shared paper, 2026 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.